Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norepinephrine Gene Polymorphisms and Methylphenidate Response in ADHD
NCT00862108Phase 4Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate hydrochloride extended-release chewable tablet in attention deficit hyperactivity disorder (ADHD), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00862108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00862108.